Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 3 to 12

Using N-acetylcysteine to reduce repetitive behaviors in children with autism

Official title: Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: A Randomized, Controlled Trial

Run by Stanford University · NCT05664789 · Data updated 2026-11-12

This study is testing if a nutritional supplement called N-acetylcysteine can help reduce repetitive behaviors in children with autism aged 3 to 12.

More Autism Spectrum Disorder trials

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages3 Years to 12 Years
SexAll
Enrollment144 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedApril 26, 2023
Main results expectedJanuary 31, 2028
Study endsJuly 31, 2028
Registry record updatedMay 15, 2026
Trial IDNCT05664789 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 12 years with a confirmed diagnosis of autism spectrum disorder and moderate severity of restricted and repetitive behaviors.

Probably not a fit

Patients with severe symptoms or those who do not meet the eligibility criteria, such as those with significant comorbid conditions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to investigate the effects of N-acetylcysteine (NAC), a nutritional supplement, on reducing restricted and repetitive behaviors in children diagnosed with autism spectrum disorder. The study will be a 12-week double-blind, randomized, placebo-controlled trial, assessing the neurobiological mechanisms of NAC through neuroimaging techniques such as MRI and EEG. Participants will include children aged 3 to 12 years with confirmed autism diagnoses and moderate severity of symptoms. The trial seeks to provide insights into the clinical benefits of NAC and its potential role in managing autism-related behaviors.

Why it matters

Potential benefit: If successful, this study could provide a new, well-tolerated treatment option for reducing repetitive behaviors in children with autism.

How similar studies have gone: Previous small-scale trials have shown promise for NAC in reducing symptoms of autism, indicating potential for success in this larger trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* children between 3 years and 12 years 11 months
* diagnosis of autism spectrum disorder confirmed with the Autism Diagnostic Interview- Revised and the Autism Diagnostic Observation Schedule-2, Brief Observation of Symptoms of Autism, or Childhood Autism Rating Scale
* at least moderate severity of restricted and repetitive behaviors defined by a Children's Yale-Brown Obsessive Compulsive Scale for Autism Spectrum Disorder score ≥ 11
* physical development indicative of prepubescence as defined by criteria for Tanner Stage 1
* if home address is within 300 miles of the primary study site, participants must pass MR safety screening (e.g., no metal in the body) and attempt baseline neuroimaging (MRI or EEG), otherwise baseline neuroimaging is not required for participation
* have stable medication regimens (≥ 30 days) and psychosocial treatments (≥ 60 days) prior to randomization with no anticipated changes during the trial

Exclusion Criteria:

* presence of known genetic abnormalities associated with ASD (e.g. Fragile X)
* current or life-time diagnosis of severe psychiatric disorder (e.g., schizophrenia)
* presence of significant medical problems
* the inability of at least one caregiver to speak and read English to a sufficient level
* participants taking glutathione agents/prodrugs
* history of any adverse effects to glutathione agents/prodrugs
* the inability to drink a sample study compound dissolved in liquid

Where it's running

  • Department of Psychiatry and Behavioral Sciences
    Palo Alto, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.